12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Ironwood, AstraZeneca sales and marketing update

Ironwood said in its 4Q12 earnings that it received rights from AstraZeneca to co-promote Nexium esomeprazole...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >